Johnson & Johnson and partner Sanofi will stop a late-stage trial of an experimental vaccine to prevent infections caused by ...

Johnson & Johnson said on Thursday it will discontinue a late-stage study of an experimental E.coli vaccine it was developing ...

Johnson & Johnson and Sanofi said that while the vaccine showed no safety concerns, it did not meet the necessary ...

Visits to McDonald’s plunged because of an E. coli outbreak last fall — and so did its profits. Fourth-quarter sales at ...

During an inspection, E. coli was found at 1,000 times the legal limit in Crosby, Texas, roughly 30 minutes northeast of Houston. Although the contaminated water isn't getting into the region's ...

By analyzing E. coli protein levels, scientists found a surplus of membrane shuttle proteins that may play a role in ...

Due to the discontinuation, Sanofi said that it has recorded an impairment charge before tax of $250 million in the Q4 2024 ...

Sanofi SA (NASDAQ:SNY) and Johnson & Johnson (NYSE:JNJ) have discontinued the E.mbrace phase 3 study evaluating a vaccine ...

Darwin's theory of natural selection provides an explanation for why organisms develop traits that help them survive and reproduce.

Nuking leftovers at work might not seem like a health risk, but those microwaves can often be a hotbed for bacteria. One ...

The Netherlands Food and Consumer Product Safety Authority (NVWA) has issued another recall over potential E.coli ...

A Cornell University-led collaboration has uncovered the equipment that enables bacteria to survive exposure to antibiotics: a shuttling mechanism that helps a complex of proteins pump out a wide ...